New cancer clinical trial: Unraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA)

Published on: February 04, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share